A Prospective Multicentre Study to Evaluate the Efficacy and Tolerability of Osmotic Release Oral System (Oros®) Hydromorphone in Opioid-Naive Cancer Patients: Results of the Korean South West Oncology Group Study

Eun-Kee Song; Hyunjeong Shim; Hye-Suk Han; DerSheng Sun; Soon-Il Lee; Myung Hee Kang; KyuTaek Lee; DoYeun Cho; In Sung Cho; Suk Young Park; Samyong Kim; Chang-Yeol Yim

doi:10.1155/2015/458389

Pain Research and Management (Jan 2015)

A Prospective Multicentre Study to Evaluate the Efficacy and Tolerability of Osmotic Release Oral System (Oros®) Hydromorphone in Opioid-Naive Cancer Patients: Results of the Korean South West Oncology Group Study

Eun-Kee Song,
Hyunjeong Shim,
Hye-Suk Han,
DerSheng Sun,
Soon-Il Lee,
Myung Hee Kang,
KyuTaek Lee,
DoYeun Cho,
In Sung Cho,
Suk Young Park,
Samyong Kim,
Chang-Yeol Yim

Affiliations

Eun-Kee Song: Department of Internal Medicine, Chonbuk National University Medical School and Research Institute of Clinical Medicine of Chonbuk National University – Biomedical Research Institute of Chonbuk National University Hospital, Jeonju, Republic of Korea
Hyunjeong Shim: Department of Internal Medicine, Chonnam National University Hwasun Hospital, Gwangju, Republic of Korea
Hye-Suk Han: Department of Internal Medicine, College of Medicine, Chungbuk National University, Cheongju, Republic of Korea
DerSheng Sun: Department of Internal Medicine, St. Mary’s Hospital, Cheongju, Republic of Korea
Soon-Il Lee: Department of Internal Medicine, Dankook University Hospital, Choenan, Republic of Korea
Myung Hee Kang: Department of Internal Medicine, Gyeongsang National University Hospital, Jinju, Republic of Korea
KyuTaek Lee: Department of Internal Medicine, Soon Chun Hyang University Cheonan Hospital, Cheonan, Republic of Korea
DoYeun Cho: Department of Internal Medicine, Konyang University Hospital, Nonsan, Republic of Korea
In Sung Cho: Department of Internal Medicine, Eulji University Hospital, Republic of Korea
Suk Young Park: Department of Internal Medicine, The Catholic University Korea Daejeon St Mary’s Hospital, Republic of Korea
Samyong Kim: Department of Internal Medicine, Chungnam National University Hospital, Deajeon, Republic of Korea
Chang-Yeol Yim: Department of Internal Medicine, Chonbuk National University Medical School and Research Institute of Clinical Medicine of Chonbuk National University – Biomedical Research Institute of Chonbuk National University Hospital, Jeonju, Republic of Korea

DOI: https://doi.org/10.1155/2015/458389
Journal volume & issue: Vol. 20, no. 6
pp. 293 – 299

Abstract

Read online

BACKGROUND: Osmotic release oral system (OROS®) hydromorphone is a potent, long-acting opioid analgesic, effective and safe for controlling cancer pain in patients who have received other strong opioids. To date, few studies have examined the efficacy of hydromorphone for pain relief in opioid-naive cancer patients.

Published in Pain Research and Management

ISSN: 1203-6765 (Print); 1918-1523 (Online)
Publisher: Wiley
Country of publisher: United Kingdom
LCC subjects: Medicine: Medicine (General)
Website: https://onlinelibrary.wiley.com/journal/7040

About the journal